2616
vs
ABBV
2616
ABBV
Over the past 12 months, CStone Pharmaceuticals has significantly outperformed ABBV, delivering a return of +126% compared to the ABBV's +30% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
2616
ABBV